Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Kidney International Reports - United States
doi 10.1016/j.ekir.2017.11.004
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

AB0597 Low-Dose Rituximab as Induction Therapy for Japanese Patients With Anca-Associated Vasculitis

2017English

Intravenous Cyclophosphamide and Plasmapheresis in Dialysis-Dependent ANCA-Associated Vasculitis

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2012English

Microscopic Haematuria in ANCA-Associated Vasculitis With Glomerulonephritis During Treatment and Remission

Journal of Vasculitis
2016English

Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Rituximab Induces Remission in Refractory HCV Associated Cryoglobulinaemic Vasculitis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Concurrent Diffuse Alveolar Haemorrhage and Venous Thromboembolism in P-Anca Associated Vasculitis Treated With Rituximab

BMJ Case Reports
Medicine
2014English

SAT0527 Rituximab Prescription Patterns and Efficacy in the Induction Treatment of Anca-Associated Vasculitis in a Belgian Multicentric Cohort

2018English

Proteinase 3-Anca Vasculitis Versus Myeloperoxidase-Anca Vasculitis

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Induction of Remission in Active Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis With Mycophenolate Mofetil in Patients Who Cannot Be Treated With Cyclophosphamide

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy